Topical Drugs CDMO Market
The Topical Drugs CDMO market consists of specialized companies that provide contract development and manufacturing services for pharmaceutical products applied to the skin or mucous membranes. The main customers are pharmaceutical and biopharmaceutical companies that outsource these functions. Key growth drivers include the rising global prevalence of skin conditions like eczema and psoriasis, and a growing trend of outsourcing within the pharma industry to improve cost-efficiency and manufacturing flexibility.
CAGR
10.3%
Compound Annual Growth Rate
Current Value
$57.3B
Estimated 2026
Projected Value
$125.4B
By 2034